dioscin has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lu, Z; Peng, JY; Wang, J; Yao, Y | 1 |
| Han, X; Jin, Y; Liu, KX; Peng, JY; Qi, Y; Xu, LN; Xu, YW; Yin, LH; Zhao, YY | 1 |
| Bing, L; Xie, Y; Yu, F; Yu, W | 1 |
3 other study(ies) available for dioscin and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Dioscin ameliorates diabetes cognitive dysfunction via adjusting P2X7R/NLRP3 signal.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Diosgenin; Disease Models, Animal; Inflammasomes; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Receptors, Purinergic P2X7; Signal Transduction | 2021 |
Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Diosgenin; Gene Expression Regulation; Gluconeogenesis; Glycolipids; Hep G2 Cells; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin Resistance; Lipogenesis; Liver; Male; Mice, Inbred C57BL; MicroRNAs; Rats, Wistar; STAT3 Transcription Factor | 2020 |
Dioscin Promotes Proliferation of Pancreatic Beta Cells via Wnt/β-Catenin Signaling Pathways.
Topics: Apoptosis; beta Catenin; Cell Line; Cell Proliferation; Cell Survival; Diabetes Mellitus, Type 2; Diosgenin; Glucose; Glycogen Synthase Kinase 3 beta; Humans; Insulin-Secreting Cells; Wnt Signaling Pathway | 2018 |